{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-222443","form_type":"8-K","ticker":"FULC","cik":"0001680581","company_name":"Fulcrum Therapeutics, Inc.","filed_at":"2022-08-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:56.639773+00:00","generated_at":"2026-06-23T23:09:44.581643+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Fulcrum Therapeutics announces $75M public offering of common stock at $7.82/share","bullets":["9,590,792 shares offered at $7.82/share; gross proceeds $75 million.","Net proceeds estimated at $70.3 million ($80.9 million if underwriters exercise full 30-day option for 1,438,618 additional shares).","Goldman Sachs & Co. and SVB Securities act as lead joint book-running managers; closing expected on August 18, 2022.","Company subject to 60-day lock-up; directors and executive officers subject to 30-day lock-up."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-222443","json":"https://secwatch.observer/filing/0001193125-22-222443.json","markdown":"https://secwatch.observer/filing/0001193125-22-222443.md","text":"https://secwatch.observer/filing/0001193125-22-222443.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1680581/000119312522222443/0001193125-22-222443-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1680581/000119312522222443/d284968d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T23:09:44.581643+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}